Dara Wright - Dec 16, 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIOB)

Role
EVP, President, CDG
Signature
/s/ Dara Wright
Stock symbol
BIO BIOB
Transactions as of
Dec 16, 2023
Transactions value $
-$53,265
Form type
4
Date filed
12/19/2023, 12:19 PM
Previous filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +502 +33.49% $0.00 2K Dec 16, 2023 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability -$53.3K -174 -8.7% $306.12 1.83K Dec 16, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -502 -49.95% $0.00 503 Dec 16, 2023 Bio-Rad A Common Stock 502 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date.